News
The U.S. Food and Drug Administration’s (FDA’s) evolving guidance on Computer Software Assurance and AI/ML-Based Software ...
Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 ...
Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some ...
Torrent has signed definitive agreements to acquire stake in JB Pharma at an equity valuation of Rs256.89bn ($3bn) on a fully ...
Sanofi's antibody riliprubart has received orphan drug designation from Japan's MHLW for its potential to treat CIDP.
Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...
BioVersys and Shionogi have entered a research and exclusive licence option agreement for the co-development of new ansamycin leads.
A new podcast from industry experts MarketScan explains why social determinants of health are critical to patient care.
As the pharma sector braces for sector-specific tariffs from President Trump, what could the impact look like on supply ...
Vetter Pharma, has begun the construction of a new clinical manufacturing facility in Des Plaines, Illinois, US.
Modella AI has signed a multi-year agreement with AstraZeneca for expediting AI-driven oncology clinical development.
The FDA has approved Sobi's Gamifant (emapalumab) to treat adults and children with HLH/MAS associated with Still’s disease, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results